REGENXBIO Inc. ($RGNX)
Filing Information
| Accession Number | 0001700659-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,483
Total Value
$46,461.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 2, 2026 | Exercise/Conversion | 2,161 | $7.86 | $16,985.46 | 215,170 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 2, 2026 | Sale | 2,161 | $13.64 | $29,476.04 | 213,009 | Direct | โ | View Details | |
Chief Medical Officer | Stock Options (Right to Buy) | Derivative | Jul 2, 2026 | Exercise/Conversion | 2,161 | $0.00 | $0.00 | 64,812 | Direct | โ | View Details |